Comparison of clinical features between patients with RARS and RARS-T
. | RARS . | RARS-T . | P value . |
|---|---|---|---|
| Platelet count greater than 500 × 109/L | 0 of 9 | 9 of 9 | .01 |
| ANC greater than 0.5 × 109/L | 9 of 9 | 9 of 9 | > .999 |
| Increased BM megakaryocytes | 3 of 9 | 8 of 9 | .27 |
| Abnormal megakaryocyte morphology | 1 of 6 | 6 of 9 | .35 |
| BM blasts fewer than 5% | 9 of 9 | 9 of 9 | > .999 |
| Increased BM cellularity | 7 of 9 | 9 of 9 | .74 |
| MCV greater than 100 fL | 3 of 9 | 5 of 9 | .68 |
| Splenomegaly | 0 of 9 | 4 of 9 | .11 |
| Reticulin fibrosis | 0 of 9 | 7 of 9 | .02 |
| Abnormal cytogenetics | 2 of 8 | 3 of 9 | > .999 |
| JAK2 V617F mutation | 0 of 9 | 6 of 9 | .05 |
. | RARS . | RARS-T . | P value . |
|---|---|---|---|
| Platelet count greater than 500 × 109/L | 0 of 9 | 9 of 9 | .01 |
| ANC greater than 0.5 × 109/L | 9 of 9 | 9 of 9 | > .999 |
| Increased BM megakaryocytes | 3 of 9 | 8 of 9 | .27 |
| Abnormal megakaryocyte morphology | 1 of 6 | 6 of 9 | .35 |
| BM blasts fewer than 5% | 9 of 9 | 9 of 9 | > .999 |
| Increased BM cellularity | 7 of 9 | 9 of 9 | .74 |
| MCV greater than 100 fL | 3 of 9 | 5 of 9 | .68 |
| Splenomegaly | 0 of 9 | 4 of 9 | .11 |
| Reticulin fibrosis | 0 of 9 | 7 of 9 | .02 |
| Abnormal cytogenetics | 2 of 8 | 3 of 9 | > .999 |
| JAK2 V617F mutation | 0 of 9 | 6 of 9 | .05 |